Review
Open access
Aug 2026
The current clinical trial landscape in idiopathic inflammatory myopathies.
PURPOSE OF REVIEW In recent years, advances in the understanding of idiopathic inflammatory myopathies (IIM) pathogenesis have led to the development of targeted therapies directed against key immune pathways. This review highlights recent advances in clinical trials, emerging therapeutic strategies, and the rapidly ev...
Nikola Wilk, Julie J. Paik, Merrilee Needham et al.
· Current Opinion in Rheumatol... · 0 citations